Hamilton Wealth’s AbbVie ABBV Stock Holding History

Hamilton Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.52M	Sell	21,955 -365	-2%	-$78.5K	1.01%	30
2026 Q1	$4.85M	Buy	22,320 +96	+0.4%	+$21.3K	0.95%	29
2025 Q4	$5.08M	Buy	22,224 +995	+5%	+$227K	0.97%	27
2025 Q3	$4.92M	Buy	+21,229	New	+$4.32M	1.03%	27
2025 Q2	–	Sell	-1,160	Closed	-$243K	–	105
2025 Q1	$243K	Buy	+1,160	New	+$226K	0.06%	88
2020 Q3	–	Sell	-21,349	Closed	-$2.1M	–	52
2020 Q2	$2.1M	Sell	21,349 -18,036	-46%	-$1.59M	1.25%	26
2020 Q1	$3M	Buy	+39,385	New	+$3.35M	2.24%	23

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Hamilton Wealth's ABBV Position: Q2 2026 in Review

Hamilton Wealth reduced its AbbVie (ABBV) stake by 1.6% in Q2 2026, selling an estimated $78.5K and leaving 21,955 shares worth $5.52M. The position accounts for 1.01% of the portfolio, ranked #30.

Hamilton Wealth first reported a position in ABBV in Q1 2020 and has held it in 7 quarters since. 4,225 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Hamilton Wealth held 21,955 shares of AbbVie worth $5.52M as of Q2 2026.
Hamilton Wealth sold 365 AbbVie shares in Q2 2026, an estimated $78.5K.
AbbVie made up 1.01% of Hamilton Wealth's portfolio in Q2 2026, its #30 holding.
Hamilton Wealth first reported a position in AbbVie in Q1 2020 and has held it in 7 quarters since.
4,225 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Hamilton Wealth's 13F filing for Q2 2026, filed 6 Aug 2026.